Henan Taloph Pharmaceutical Stock Co Ltd banner

Henan Taloph Pharmaceutical Stock Co Ltd
SSE:600222

Watchlist Manager
Henan Taloph Pharmaceutical Stock Co Ltd Logo
Henan Taloph Pharmaceutical Stock Co Ltd
SSE:600222
Watchlist
Price: 7.11 CNY
Market Cap: ¥4.1B

Henan Taloph Pharmaceutical Stock Co Ltd
Investor Relations

Henan Taloph Pharmaceutical Stock Co., Ltd. engages in the pharmaceutical manufacturing industry. The company is headquartered in Zhengzhou, Henan and currently employs 2,209 full-time employees. The firm provides oral solutions, transfusion and tablets, which are applied in the treatment of cold, diabetes and virus infection. The firm's main products include Shuanghuanglian oral liquid products, double gold agents, Haberffine tablets and compound Yimu oral solutions, among others. The firm distributes its products mainly within domestic market.

Show more
Loading
600222
Shanghai Composite
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Jingliang Li
GM & Vice Chairman
No Bio Available
Mr. Hailin Zhao
CFO & Executive Deputy GM
No Bio Available
Mr. Fengshan Su
Deputy General Manager
No Bio Available

Contacts

Address
HENAN
Zhengzhou
No. 8, Jinsuo Road, Hi-Tech Industrial Development Zone
Contacts
+8637167992262
www.taloph.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett